GoldenGolden
Advanced Search
Libra Therapeutics

Libra Therapeutics

Libra Therapeutics is a small Molecules for Neurodegenerative Indications.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

September 2020
Libra Therapeutics raises a $29,000,000 series A round from Boehringer Ingelheim Venture Fund, Dolby Family Ventures, Epidarex Capital, Sante Ventures, Sixty Degree Capital and Yonjin Capital.

Funding rounds

Patents

Products

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.